Biotech: Zug-based CRISPR Therapeutics reported early results for its experimental gene-edited CAR-T therapy in autoimmune diseases: all nine patients in the muscle-disease group responded, while 5 of 6 systemic-sclerosis patients showed a clinical response. Space Science: Former NASA chief scientist Thomas Zurbuchen received the 2026 Prix Suisse. A University of Bern physics graduate, he now leads ETH Zurich’s Space Department. Archaeology: A Bern-linked team found cannabis seeds and chemical traces in hair from a 2,800-year-old Siberian tomb, offering the oldest directly dated evidence of cannabis use for intoxication. Swiss Tech: China’s move to block SoftBank’s $5.4 billion purchase of ABB’s robotics division puts a major deal involving the Swiss engineering group in doubt. Dental Tech: Swiss startup vVardis is targeting a US IPO valuation of up to $4.4 billion.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Brain Research: University of Zurich scientists found that support cells in adult mouse brains can multiply and refill damaged areas, pointing to a potential new avenue for treating brain disorders. Similar cells were observed in tissue from people with a rare neurological disease. Bioelectronics: ETH Zurich researchers have developed a wireless implant that lowered blood sugar in diabetic mice by converting excess glucose into a compound the body can remove. It remains experimental and is years from human trials. Swiss Pharma: Novartis’s pelacarsen sharply reduced a cardiovascular risk marker in a major trial but did not significantly cut heart attacks, strokes or related deaths, raising questions about the drug’s clinical value. Robotics: ABB and SoftBank are reportedly exploring a separate ownership structure for ABB’s China robotics business after Beijing blocked their $5.4 billion deal. China accounts for about 30% of ABB Robotics’ business. Swiss Tech: Dental startup vVardis is targeting a valuation of up to $4.4 billion in a planned US IPO.
Robotics: China has blocked SoftBank’s $5.4 billion purchase of ABB’s robotics business. ABB and SoftBank are reportedly weighing a carve-out of the Chinese operations, a key market for ABB, as Beijing tightens scrutiny of strategic technology deals. Medical Research: ETH Zurich researchers have demonstrated a wireless, battery-free implant that uses electrochemistry to reduce blood sugar in diabetic mice. Human trials are still years away. Swiss Startups: Dental-tech company vVardis is targeting a US IPO that could value it at up to $4.4 billion. Gene Therapy: Novartis has reported nine cases of tumors in children treated with its Zolgensma gene therapy, prompting renewed attention to the treatment’s safety.
Biotech Safety: Novartis reported nine cases of tumors in children treated with its gene therapy Zolgensma; two cases showed signs that the therapy’s delivery virus had integrated into patients’ DNA. The company says it has notified health authorities. Swiss Innovation: Air-quality company IQAir unveiled a sustainably designed purifier in China, its second-largest market, where it says it tests products for global use. Robotics: China blocked SoftBank’s planned $5.4 billion purchase of ABB Robotics, citing concerns that AI-training data could be transferred overseas. Dental Tech: Swiss startup vVardis is seeking a US IPO valuation of up to $4.37 billion, betting on its non-invasive treatment for early tooth decay. Archaeology: University of Bern researcher Gino Caspari co-authored a study identifying cannabis seeds and chemical traces in hair from a Siberian tomb, suggesting intoxicating use about 2,800 years ago.
Data Centre Backlash: Greenpeace activists unfurled a giant banner beside a data-centre site in Beringen, warning that planned facilities could use around 1.5 times Schaffhausen canton’s annual electricity. The group wants a moratorium until stronger rules protect resources. Swiss Robotics: Embodied AI has unveiled AIR, a humanoid robot designed to work alongside factory staff. It learns tasks from human demonstrations, with safety built into its design. Gene Therapy Safety: Novartis confirmed nine reported tumors in children treated with its Zolgensma gene therapy, including two cases with signs of the treatment’s vector integrating into patients’ DNA. Bern Research: A University of Bern-led team found cannabis seeds and chemical traces in hair from a Siberian tomb, identifying the oldest directly dated evidence of cannabis used as an intoxicant. Quantum Security: Geneva-based SEALSQ and TechAgency are teaming up to help organizations assess and prepare for the shift to quantum-resistant encryption. Research Careers: A European survey ranks Switzerland fifth for doctoral-candidate pay, with annual remuneration of about €49,675.
Swiss Biotech: Zurich-based Molecular Partners reported preclinical results for MP0632, a T-cell engager designed to attack tumors while sparing healthy tissue. The company says the findings support moving toward studies needed before human trials. Robotics Deal: China blocked SoftBank’s planned $5.4 billion purchase of ABB’s robotics business in China, disrupting a major deal for the Swiss-Swedish industrial group. AI & Vision: A research team including ETH Zurich scientists used AI to improve brain stimulation in a blind participant, a step toward more precise visual prostheses. Swisscom: The telecom firm raised its 2026 outlook slightly after nine-month core earnings increased to CHF 3.83 billion. Ancient Science: A Bern archaeologist co-authored research identifying cannabis use for its psychoactive effects in a Siberian tomb dating back about 2,800 years.
ABB Robotics: China has blocked SoftBank’s $5.4 billion takeover of ABB’s robotics division, citing concerns that robotics data could be transferred abroad and used to train AI models. ABB and SoftBank say they are still discussing the deal. Quantum Materials: Researchers at Switzerland’s Paul Scherrer Institute found that pressure can make superconductivity spread through layered tantalum disulfide, at temperatures about three times higher than before. Secure Chips: Kudelski Labs and u-blox are expanding their collaboration on next-generation secure semiconductor platforms. Swiss Pharma: A new industry index says Switzerland is lagging in pharmaceutical technology and clinical trials. Space Research: A Swiss satellite is being developed to improve solar-storm forecasts. AI and Jobs: Proton’s CEO says AI could sharply change software engineering recruitment, while the company has denied plans for AI-related job losses.
Swiss Biotech: Molecular Partners plans to present its DLL3-targeting radio-DARPin MP0712 at upcoming cancer and theranostics conferences, including early trial data. Cybersecurity: A wave of attacks on European supermarket fridges highlights risks from connected devices; a University of St. Gallen expert says outdated systems can leave them exposed. Particle Physics: New signals from the “zeptoverse,” captured in experiments at CERN’s Large Hadron Collider on the Swiss-French border, could help researchers build a fuller theory of the universe. AI and Jobs: Google is offering voluntary exit packages to eligible staff in Switzerland as it increases AI spending; DeepMind and Google Cloud are excluded. Life Sciences: Lonza plans to buy five US manufacturing sites from Merck, expanding its contract drug-manufacturing footprint. Robotics: ETH Zurich researchers have developed a flexible drone designed to withstand collisions.
Open Science: CERN is managing an expanded Open Research Europe platform, where researchers in 11 countries can publish papers free and make peer review more transparent. ETH Zurich: Researchers have developed a wireless implant that lowered blood sugar in mice by electrically converting glucose into gluconate. The team plans larger-animal tests before considering human trials. Another ETH method can preserve a record of gene activity in cells for several days, potentially helping researchers study how cancer cells respond to treatment. Swiss Biotech: A new index says Switzerland’s pharmaceutical industry is lagging in technology and clinical trials, even as Lonza moves to more than double its US manufacturing footprint by buying five sites from Merck. Everyday Health Tech: ETH engineers have also built a portable breath device that measures acetone, a marker of fat burning, and can be used with a smartphone app.
Biotech: Swiss drugmaker Idorsia says the FDA granted breakthrough status to daridorexant for insomnia in 10- to 17-year-olds, a group with no FDA-approved drug treatments. Life Sciences Industry: Lonza is buying five US manufacturing sites from Merck KGaA, expanding its production footprint and deepening its contract drug-manufacturing business. Robotics: ETH Zurich has developed a flexible drone designed to withstand collisions. AI: Proton CEO Andy Yen says the company expects AI to handle most coding and plans to stop hiring software engineers after 2026. Space Science: A Swiss satellite is set to improve forecasts of solar storms, which can disrupt satellites and communications.
Biopharma: Lonza will acquire five US manufacturing sites from Merck at a low-to-mid triple-digit-million-franc valuation, adding about 1,100 employees and capabilities in viral vectors and other complex medicines. The deal is expected to close in 2027. Swiss Health Research: An ETH Zurich team’s wireless implant converted glucose into a compound the kidneys can flush out. It brought blood sugar back to normal in diabetic mice, but remains experimental. AI and Health: Four in ten Swiss use AI for self-diagnosis, raising questions about how people rely on chatbots for medical advice. Digital Infrastructure: Swiss Federal Railways stations are deploying OpenRoaming Wi-Fi, while Indonesia’s Nongsa Digital Park has partnered with Swiss firm PHOENIQS AG on sovereign AI. Blockchain: A new Swiss Blockchain Federation benchmark ranks Switzerland sixth among 15 financial centres for digital-asset infrastructure, noting the country must keep pace with international rivals.
Precision Sensing: EPFL researchers found that nearby insulating materials can increase energy loss in nanomechanical resonators by up to tenfold, limiting the performance of ultra-sensitive sensors and quantum devices. Swiss AI: Proton has backed away from plans to re-interview staff about AI use, promising no AI-related job losses and reaffirming its security commitments. Rider Tech: Swiss company Aegis Rider has launched an augmented-reality motorcycle helmet that displays information in front of the rider without requiring a glance at the dashboard. Space Weather: A Swiss satellite is set to improve solar-storm forecasting, which could help protect technology vulnerable to space weather. Industrial Automation: Zurich-based ABB will supply automation, controls and predictive-maintenance technology for two aluminum rolling mills in China. Climate Science: UN reports warn that exceeding 1.5°C of warming risks irreversible damage to glaciers and other ice; Switzerland has already lost about 20% of its glacial mass.
AI and Jobs: Proton CEO Andy Yen reportedly told staff that 2026 would be the company’s last year hiring engineers as it shifts more coding to AI. Proton later denied plans for job cuts. Space: A Swiss satellite is set to improve solar-storm forecasts, which could help protect infrastructure from space-weather disruption. Medical Research: ETH Zurich researchers developed an electrical implant that helped lower blood sugar and weight in diabetic mice by converting excess glucose into a substance the body can eliminate. The approach is experimental. Cybersecurity: The US government is removing Swiss firm Acronis’s products from federal systems after years of scrutiny over development ties in Russia. Officials reportedly found no concrete evidence of backdoors. Climate Science: UN-backed reports warn that breaching 1.5°C of warming could cause irreversible damage to glaciers and other ice systems; Switzerland has already lost 20% of its glacier ice in five years.
Industrial Technology: Swiss marine-engine maker WinGD has signed its first licensing deal with South Korea’s HD Hyundai Marine Engine, widening access to its dual-fuel and diesel designs for bulk carriers and tankers. Robotics: ETH Zurich researchers built a soft robotic hand that walks on its fingertips. The work could help improve how robots move and manipulate objects. Biomedical Research: A new Basel–Oxford centre will bring immune-engineering research into diagnostics, vaccines and therapies, with a focus on children’s health. Neuroscience: A Swiss study used nanosheets inspired by ancient Egyptian blue to track immune cells in living brains in real time. AI and Jobs: Proton says it may stop hiring software engineers after 2026, as AI takes on more coding; reports also describe staff re-interviews focused on AI skills. Energy Storage: A Swiss timber producer plans to develop commercial battery storage, adding a new energy-storage project to the country’s industrial landscape.
AI at Proton: The Swiss privacy company says it does not track how much AI-generated code staff produce, pushing back against reports that sparked employee concerns. Proton acknowledged poor communication and promised more transparency about its AI plans. Child Health Research: A new Basel–Oxford centre will turn immune-engineering research into diagnostics, vaccines and therapies, with a focus on children and adolescents in lower-income countries. Swiss-China Science Links: Switzerland and China have agreed to exchange scientific data as Swiss firms look to deepen cooperation in areas including biotech and AI. The upgraded free-trade deal aims to improve market access. Climate Adaptation: Switzerland has adopted a 2026–31 plan to address heat and drought, while Swiss researchers are developing tools to help the country adapt.
AI at Proton: The Swiss privacy company says 2026 may be its last year hiring software engineers, as AI handles more coding; staff will be reassessed for AI-related roles. AI Rules: Switzerland is also advancing sector-specific AI regulation and voluntary codes of conduct. Climate Planning: The country’s climate-adaptation plan is facing criticism after a record-hot summer. Rail Tech: Stadler has won an order for 21 more trains in Finland, extending the Swiss manufacturer’s international reach. Energy Storage: A Swiss timber producer plans to build commercial battery storage, linking local industry with the energy transition. Health Tech: Roche’s cobas smart e immunoanalyser has received CE marking, completing a portfolio designed to bring central-lab testing to smaller clinics and hospitals. Swiss-China Research: The two countries have agreed to exchange scientific data and signed an upgraded trade deal that promises zero tariffs on more than 99% of imports.
Rail Expansion: Stadler Rail will supply Finland with 21 more trains under an option in its 2022 contract, extending the Swiss manufacturer’s role in the country’s passenger network. AI and Jobs: Proton says 2026 may be its final year hiring software engineers, as its CEO expects AI to handle most coding; the company is also reassessing staff roles. Swiss Research: A Swiss study reports that nanosheets made from Egyptian blue can track immune cells in living brains in real time. Drugmakers: Novartis booked about $2.2 billion in charges after trial setbacks but raised its 2026 profit outlook; Roche gained CE Mark approval for a portable immunoassay system and launched a test to help distinguish mesothelioma. Trade: Switzerland and China signed an upgraded free-trade agreement, with zero tariffs pledged on more than 99% of imports.
Proton’s AI shift: The Swiss company says AI wrote about 90% of its code in October. Staff face AI-use reviews, with jobs potentially at stake as Proton rethinks engineering hires. Swiss-China ties: President Guy Parmelin’s visit to China brought an upgraded free-trade deal, alongside calls for greater cooperation in biomedicine and AI. Brain research: A Swiss study used nanosheets inspired by ancient Egyptian blue to track immune cells in living brain tissue in real time. Medical technology: Roche received CE marking for its cobas smart e immunoanalyser and launched a test to help diagnose mesothelioma. Radiation detection: Swiss helicopter tests showed airborne scans can pinpoint hidden radioactive sources to within two metres in seconds.
AI at Proton: The Swiss privacy company says AI wrote about 90% of its code in October. CEO Andy Yen says it will stop hiring engineers after 2026, while staff face AI-use interviews that could affect their roles. Swiss-China ties: Guy Parmelin and Xi Jinping witnessed the signing of an upgraded free-trade agreement and cooperation documents, including on scientific research; the countries also agreed to exchange scientific data. Climate response: After Switzerland’s hottest summer on record, the government unveiled a heat-and-drought adaptation plan. Environmental groups and local authorities say it falls short. Tech supply chains: Ukraine says components from 11 Swiss companies have been found in Russian weapons, including drones and missiles; a Ukrainian official says Swiss parts appear in most Russian drones and missiles. Biotech pressure: Schlieren-based Molecular Partners plans to cut up to 55 jobs, about 44% of its workforce, as it focuses on targeted radiotherapy and seeks new financing.
Brain Research: EPFL neurobiologist Gioele La Manno won the 2026 Eppendorf & Science Prize for work showing how brain lipids help shape different cell types, including through a detailed lipid atlas. Lower-Carbon Construction: ETH Zurich researchers used bacteria to bind sand into building-grade material, exploring a potential alternative to energy-intensive cement. Swiss-China Research Links: Officials and businesses from Schaffhausen and China’s Hunan province discussed cooperation in biomedicine and AI, building on ties between the regions. AI Policy: Switzerland is pursuing a distinct approach to AI from the US and China, with sector-specific regulation and voluntary codes of conduct. Climate Adaptation: The government has set out a 2026–2031 plan to tackle heatwaves and drought, while Swiss researchers are developing tools to help communities adapt.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.